Novartis AG (BUE:NVS) Other Current Payables : ARS0 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Novartis AG Other Current Payables?

Novartis AG's Other Current Payables for the quarter that ended in Mar. 2024 was ARS0 Mil.

Novartis AG's quarterly Other Current Payables declined from Sep. 2023 (ARS4,886,002 Mil) to Dec. 2023 (ARS296,020 Mil) and declined from Dec. 2023 (ARS296,020 Mil) to Mar. 2024 (ARS0 Mil).

Novartis AG's annual Other Current Payables increased from Dec. 2021 (ARS59,382 Mil) to Dec. 2022 (ARS124,564 Mil) and increased from Dec. 2022 (ARS124,564 Mil) to Dec. 2023 (ARS296,020 Mil).

Novartis AG Other Current Payables Historical Data

The historical data trend for Novartis AG's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Other Current Payables Chart

Novartis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Payables

Get a 7-Day Free Trial

45,667.03

58,268.08

59,382.12

124,563.95

296,020.00

Novartis AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Payables	Get a 7-Day Free Trial															-	-	4,886,002.03	296,020.00	-

Novartis AG Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Novartis AG Other Current Payables Related Terms

Thank you for viewing the detailed overview of Novartis AG's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG (BUE:NVS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (BUE:NVS) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

NVSEF:USA NVS:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.